Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on May 11, 2021. The filing serves to announce the Company's financial results for the period ended March 31, 2021, and provides an update on recent corporate events. The report includes a press release and a letter to stockholders as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release and letter to stockholders (Exhibits 99.1 and 99.2), which are not included in the source text provided for this summary.
Material Changes
The filing indicates that material information regarding the period ended March 31, 2021, is contained within the furnished exhibits. No specific comparative data or material changes versus prior periods are explicitly stated in the body of this Form 8-K.
Guidance, Outlook, and Risks
The Company issued a press release and a letter to stockholders containing an update on recent corporate events. The filing explicitly states that the information furnished under Item 2.02, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that Section. Furthermore, the Company does not assume any obligation to update the information contained in the exhibits in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended March 31, 2021.
- Review Exhibit 99.2 (Letter to Stockholders) for details on recent corporate events and management commentary.
- Verify the status of the Company's 8.625% Senior Notes due 2026 (trading symbol HROWL) as referenced in the securities registration section.
- Confirm that the financial data in the exhibits aligns with the Company's previously issued guidance, noting the disclaimer regarding future updates.